COVID Protocols Literature Grid
Report abuse
Use this data
Sign up for free
Title
1
Obstetricians on the Coronavirus Disease 2019 (COVID-19) Front Lines and the Confusing World of Personal Protective Equipment.
2
At the Heart of the Matter: Unmasking and Addressing the Toll of COVID-19 on Diverse Populations.
3
The Importance of Long-term Care Populations in Models of COVID-19.
4
Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals
5
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1.
Drag to adjust the number of frozen columns
Author
Journal
Publication Date
DOI Link
Brief Summary
Abstract
Section
Topic
Level of Evidence
Journal Impact Factor
Key literature?
Jamieson DJ, Steinberg JP, Martinello RA, Perl TM, Rasmussen SA
Obstetrics and gynecology
6/1/2020
doi.org/10.1097/AOG.0000000000003919

As health care systems struggle to maintain adequate supplies of personal protective equipment, there is confusion and anxiety among obstetricians and others about how to best protect themselves, their coworkers, and their patients. Although use of personal protective equipment is a critical strategy to protect health care personnel from coronavirus disease 2019 (COVID-19), other strategies also need to be implemented on labor and delivery units to reduce the risk of health care-associated trans

Obstetrics
Epidemiology
Infection Control
Masks
PPE
Transmission
Physical Distancing
Fomites
Exposure Management
5.618
Haynes N, Cooper LA, Albert MA
Circulation
7/1/2020
https://doi.org/10.1161/CIRCULATIONAHA.120.048126
This is an article discussing the racial disparities present in the COVID-19 patient population. The author states that known disparities based on socioeconomic and environmental factors have made ethnic minorities more susceptible to comorbidities like hypertension, CAD, diabetes which, have subsequently made them more susceptible to COVID-19. The author suggests that to help reduce further spread and to provide support to these communities, testing should be made readily available to them in


Cardiology
Health Equity
Epidemiologic Rates
Exposure Management
Global health
Level 5- Expert Opinion, Case Report
21.054
Pillemer K, Subramanian L, Hupert N
JAMA
6/1/2020
doi.org/10.1001/jama.2020.9540
A viewpoint exploring the flaws with policy modeling that does not account for long-term care residents given the disproportionate burden of disease among that population.

In February 2020, the US outbreak of novel coronavirus disease 2019 (COVID-19) began with a cluster of cases at a long-term care (LTC) facility in Washington State. Since then, 34 of the 40 states with available data report that at least 40% of COVID-19-related deaths in those states have occurred in LTC facilities,1 which provide ideal conditions for rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although the populations in these facilities bear a significant burd

Health Equity
Epidemiology
Nursing facilities
Exposure Management
Level 5- Expert Opinion, Case Report
47.677
Breslin et al
Am J Obstet Gynecol MFM
4/9/2020
doi.org/10.1016/j.ajogmf.2020.100118

Novel coronavirus disease 2019 is rapidly spreading throughout the New York metropolitan area since its first reported case on March 1, 2020. The state is now the epicenter of coronavirus disease 2019 outbreak in the United States, with 84,735 cases reported as of April 2, 2020. We previously presented an early case series with 7 coronavirus disease 2019–positive pregnant patients, 2 of whom were diagnosed with coronavirus disease 2019 after an initial asymptomatic presentation. We now describe

Obstetrics
Epidemiology
Asymptomatic Transmission
Transmission
Exposure Management
Pregnancy
Symptoms
6.136
Gelfand JM, Armstrong AW, Bell S, Anesi GL, Blauvelt A, Calabrese C, Dommasch ED, Feldman SR, Gladman D, Kircik L, Lebwohl M, Lo Re V 3rd, Martin G, Merola JF, Scher JU, Schwartzman S, Treat JR, Van Voorhees AS, Ellebrecht CT, Fenner J, Ocon A, Syed MN, Weinstein EJ, Smith J, Gondo G, Heydon S, Koons S, Ritchlin CT
Journal of the American Academy of Dermatology
9/1/2020
https://doi.org/10.1016/j.jaad.2020.09.001
This article outlines the currently accepted guidelines for psoriasis management in patients with COVID-19 infection as established by a multidisciplinary task force of psoriasis specialists. These guidelines range cover a variety of issues including how the disease and its treatments impact COVID-19 risk and outcome, how medical care can be optimized during the pandemic, what patients should do to lower their risk of getting infected with severe acute respiratory syndrome coronavirus 2 and what

OBJECTIVE: To provide guidance about management of psoriatic disease during the coronavirus disease 2019 (COVID-19) pandemic. STUDY DESIGN: A task force (TF) of 18 physician voting members with expertise in dermatology, rheumatology, epidemiology, infectious diseases, and critical care was convened. The TF was supplemented by nonvoting members, which included fellows and National Psoriasis Foundation (NPF) staff. Clinical questions relevant to the psoriatic disease community were informed by que

Cardiology
Rheumatology
Dermatology
Exposure Management
Rheumatic Disease
Immunosuppressed Patients
Level 5- Expert Opinion, Case Report
7.950
5 records

Alert

Lorem ipsum
Okay